Kuo-Hui Su

Dr. Kuo-Hui Su

University of Toledo College of Medicine and Life Sciences
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2011 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
YKYu Ru Kou
Yu Ru Kou
SSSong-Kun Shyue
Song-Kun Shyue
KSKuo-Hui Su
Kuo-Hui Su
JWJeng Wei
Jeng Wei
LCLi-Ching Cheng
Li-Ching Cheng
Tzong-Shyuan LeeTzong-Shyuan Lee
Tzong-Shyuan Lee
We investigated the molecular mechanism underlying the role of transient receptor potential vanilloid type 1 (TRPV1), a Ca2+-permeable non-selective cation channel, in the activation of endothelial nitric oxide (NO) synthase (eNOS) in endothelial cells (ECs) and mice. In ECs, TRPV1 ligands (evodiamine or capsaicin) promoted NO production, eNOS phosphorylation, and the formation of a TRPV1–eNOS complex, which were all abrogated by the TRPV1 antagonist capsazepine. TRPV1 ligands promoted the phosphorylation of Akt, calmodulin-dependent protein kinase II (CaMKII) and TRPV1, and increased the formation of a TRPV1–Akt–CaMKII complex. Removal of extracellular Ca2+ abolished the ligand-induced increase in the phosphorylation of Akt and CaMKII, formation of a TRPV1–eNOS complex, and eNOS activation. Inhibition of PI3K and CaMKII suppressed the ligand-induced increase in TRPV1 phosphorylation, formation of a TRPV1–eNOS complex, and eNOS activation. TRPV1 activation increased the phosphorylation of Akt, CaMKII, and eNOS in the aortas of wild-type mice but failed to activate eNOS in TRPV1-deficient aortas. Additionally, TRPV1 ligand-induced angiogenesis was diminished in eNOS- or TRPV1-deficient mice. When compared with apolipoprotein E (ApoE)-deficient mice, ApoE/TRPV1-double-knockout mice displayed reduced phosphorylation of eNOS, Akt, and CaMKII in aortas but worsened atherosclerotic lesions. TRPV1 activation in ECs may trigger Ca2+-dependent PI3K/Akt/CaMKII signalling, which leads to enhanced phosphorylation of TRPV1, increased TRPV1–eNOS complex formation, eNOS activation and, ultimately, NO production.

4 April 2016 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
KSKuo-Hui Su
Kuo-Hui Su
JCJunyue Cao
Junyue Cao
ZTZijian Tang
Zijian Tang
SDSiyuan Dai
Siyuan Dai
YHYishu He
Yishu He
CDChengkai Dai
Chengkai Dai
To cope with proteotoxic stress, cells attenuate protein synthesis. However, the precise mechanisms underlying this fundamental adaptation remain poorly defined. Here we report that mTORC1 acts as an immediate cellular sensor of proteotoxic stress. Surprisingly, the multifaceted stress-responsive kinase JNK constitutively associates with mTORC1 under normal growth conditions. On activation by proteotoxic stress, JNK phosphorylates both RAPTOR at S863 and mTOR at S567, causing partial disintegration of mTORC1 and subsequent translation inhibition. Importantly, HSF1, the central player in the proteotoxic stress response (PSR), preserves mTORC1 integrity and function by inactivating JNK, independently of its canonical transcriptional action. Thereby, HSF1 translationally augments the PSR. Beyond promoting stress resistance, this intricate HSF1–JNK–mTORC1 interplay, strikingly, regulates cell, organ and body sizes. Thus, these results illuminate a unifying mechanism that controls stress adaptation and growth.

14 February 2011 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
KSKuo-Hui Su
Kuo-Hui Su
SSSong-Kun Shyue
Song-Kun Shyue
YKYu Ru Kou
Yu Ru Kou
LCLi-Chieh Ching
Li-Chieh Ching
ACAn-Na Chiang
An-Na Chiang
Tzong-Shyuan LeeTzong-Shyuan Lee
Tzong-Shyuan Lee

15 March 2017 in BioEssays
Verified
Journal Article
Closed access
PDF file
KSKuo-Hui Su
Kuo-Hui Su
CDChengkai Dai
Chengkai Dai

8 November 2011 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
HHHsin-Han Hou
Hsin-Han Hou
BHBruce D. Hammock
Bruce D. Hammock
KSKuo-Hui Su
Kuo-Hui Su
CMChristophe Morisseau
Christophe Morisseau
YKYu Ru Kou
Yu Ru Kou
Tzong-Shyuan LeeTzong-Shyuan Lee
Tzong-Shyuan Lee
The mammalian soluble epoxide hydrolase (sEH) has both an epoxide hydrolase and a phosphatase domain. The role of sEH hydrolase activity in the metabolism of epoxyeicosatrienoic acids (EETs) and the activation of endothelial nitric oxide synthase (eNOS) in endothelial cells (ECs) has been well defined. However, far less is known about the role of sEH phosphatase activity in eNOS activation. In the present study, we investigated whether the phosphatase domain of sEH was involved in the eNOS activation in ECs. The level of eNOS phosphorylation in aortas is higher in the sEH knockout (sEH−/−) mice than in wild-type mice. In ECs, pharmacological inhibition of sEH phosphatase or overexpressing sEH with an inactive phosphatase domain enhanced vascular endothelial growth factor (VEGF)-induced NO production and eNOS phosphorylation. In contrast, overexpressing the phosphatase domain of sEH prevented the VEGF-mediated NO production and eNOS phosphorylation at Ser617, Ser635, and Ser1179. Additionally, treatment with VEGF induced a c-Src kinase-dependent increase in transient tyrosine phosphorylation of sEH and the formation of a sEH–eNOS complex, which was abolished by treatment with a c-Src kinase inhibitor, PP1, or the c-Src dominant-negative mutant K298M. We also demonstrated that the phosphatase domain of sEH played a key role in VEGF-induced angiogenesis by detecting the tube formation in ECs and neovascularization in Matrigel plugs in mice. In addition to epoxide hydrolase activity, phosphatase activity of sEH plays a pivotal role in the regulation of eNOS activity and NO-mediated EC functions.

3 September 2014 in Acta Physiologica
Verified
Journal Article
Closed access
PDF file
KSKuo-Hui Su
Kuo-Hui Su
SLS.‐J. Lin
S.‐J. Lin
JWJ. Wei
J. Wei
KLK.‐I. Lee
K.‐I. Lee
JZJ.‐F. Zhao
J.‐F. Zhao
Tzong-Shyuan LeeTzong-Shyuan Lee
Tzong-Shyuan Lee